PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Sodium valproate (NON childbearing potential) - Epilepsy
PAD Profile : Sodium valproate (NON childbearing potential) - Epilepsy
Keywords :
valproic acid
Brand Names Include :
Epilim, Chrono, Chronosphere, Episenta, Epival CR, Dyzantil
Traffic Light Status
Status 1 of 3.
Status :
Blue
Formulations :
- Crushable tablets
- Gastro-resistant tablets
- Modified release tablets
- Oral solution
- Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Blue
Formulations :
- Capsules (slow release)
- Granules (slow release)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Guidelines
No guidelines returned.
Other Drugs
- Eslicarbazepine acetate
- Carbamazepine
- Clobazam
- Lacosamide
- Clonazepam
- Perampanel
- Ethosuximide
- Felbamate
- Rufinamide
- Gabapentin
- Stiripentol
- Lamotrigine
- Zonisamide
- Levetiracetam
- Oxcarbazepine
- Phenobarbital
- Piracetam
- Phenytoin
- Pregabalin
- Topiramate
- Brivaracetam
- Sodium valproate
- Cannabidiol
- Vigabatrin
- Cenobamate
- Primidone
- Tiagabine
Other Indications
Additional Documents
Type
Document
Review Date
Guidelines (National)
01 April 2021
Shared Care
01 November 2021
Committee Recommendations
Date
Committee Name
Narrative
05 March 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network (PCN) recommends sodium valproate (all brands and salts) for males or females who are NOT of childbearing potential for the treatment of epilepsy or bipolar disorder.
Sodium valproate for these indications and for this cohort of patients will be considered BLUE (with an information sheet) on the traffic light system.
The specialist will prescribe a minimum of 1 month of sodium valproate at initiation and transfer of care will be requested with the patient’s primary care prescriber, once the patient is stable.
Associated BNF Codes
04. Central Nervous System
04.08.01. Control of epilepsy